量化监狱环境中男性的心血管疾病风险和心脏年龄预测
B J Gray1, C Craddock1, Z Couzens1
1Health Protection, Public Health Wales, Cardiff, UK.
Public health
|November 13, 2023
概括
监狱囚犯的心血管疾病 (CVD) 风险增加了一倍,心脏年龄比他们的时间年龄大近十年. 这凸显了在这个人群中早期进行心血管疾病查的需要.
科学领域:
- 公共卫生 公共卫生
- 心脏病学 心脏病学
- 犯罪学 犯罪学
背景情况:
- 心血管疾病 (CVD) 和其风险因素在监狱人口中表现得更早.
- 心血管疾病在很大程度上是可以预防的,因此需要对被监禁的人进行彻底的风险评估.
- 了解监狱中心血管疾病风险对于有针对性的公共卫生干预至关重要.
研究的目的:
- 为了探索男性囚犯中相对预测的10年心血管疾病风险.
- 为了检查计算的心脏年龄与这个队列的时间年龄相比.
- 量化监狱人口与普通社区之间心血管疾病风险的差异.
主要方法:
- 一项涉及299名25-84岁男性的横截面研究,在HMP Parc,Bridgend.
- 使用QRISK2算法进行心脏代谢风险评估,以计算10年心血管疾病风险和心脏年龄.
- 监狱人口与普通社区之间的心血管疾病风险预测的比较.
主要成果:
- 与一般社区相比,监狱人口的预测10年心血管疾病得分的相对风险是一般社区的两倍 (2.1 ± 0.6).
- 监狱中50岁及以上的50岁及以上的囚犯的10年心血管疾病风险为17.0%,而社区的风险为8.8% (P < 0.001).
- 平均心脏年龄比时间学年龄高7.5岁,年龄≥40岁的人增加到9岁以上.
结论:
- 可量化的证据证实,在监狱人口中,心血管疾病风险显著增加.
- 对于40岁及以上的囚犯来说,心脏年龄的预测要高得多 (近十年).
- 应该考虑在监狱人口中将心血管疾病查年龄降低约5岁.
相关概念视频
01:26Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
01:23Assessment of the Cardiovascular System I: Subjective Data
345
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
345
01:30Coronary Artery Disease I: Introduction
17
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
17
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
18
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
18
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
573
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
573
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
98
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
98